Cargando…
A Sanger sequencing protocol for SARS‐CoV‐2 S‐gene
We describe a Sanger sequencing protocol for SARS‐CoV‐2 S‐gene the Spike (S)‐glycoprotein product of which, composed of receptor‐binding (S1) and membrane fusion (S2) segments, is the target of vaccines used to combat COVID‐19. The protocol can be used in laboratories with basic Sanger sequencing ca...
Autores principales: | Daniels, Rodney S., Harvey, Ruth, Ermetal, Burcu, Xiang, Zheng, Galiano, Monica, Adams, Lorin, McCauley, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447197/ https://www.ncbi.nlm.nih.gov/pubmed/34346163 http://dx.doi.org/10.1111/irv.12892 |
Ejemplares similares
-
Temporal and Gene Reassortment Analysis of Influenza C Virus Outbreaks in Hong Kong, SAR, China
por: Daniels, Rodney S., et al.
Publicado: (2022) -
A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern
por: Bezerra, Matheus Filgueira, et al.
Publicado: (2021) -
Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses
por: Herman, Sandra, et al.
Publicado: (2012) -
Detection of Influenza C Virus Infection among Hospitalized Patients, Cameroon
por: Njouom, Richard, et al.
Publicado: (2019) -
Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018–2019 winter season
por: Korsun, Neli, et al.
Publicado: (2020)